Niacin vs. Clopidogrel: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Niacin and Clopidogrel. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 147,817 people who take Niacin and Clopidogrel, and is updated regularly.
What is Niacin?
Niacin has active ingredients of niacin. It is often used in high blood cholesterol. eHealthMe is studying from 9,009 Niacin users. Check the latest studies of Niacin.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.
147,817 people who take Niacin and Clopidogrel are studied.
Drugs being compared in this study:
- Niacin (niacin)
- Clopidogrel (clopidogrel)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Niacin:
- not at all: 4.09 %
- somewhat: 23.7 %
- moderate: 36.26 %
- high: 25.33 %
- very high: 10.62 %
Clopidogrel:
- not at all: 3.02 %
- somewhat: 14.74 %
- moderate: 30.65 %
- high: 42.04 %
- very high: 9.55 %
Want to compare Niacin with Clopidogrel?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Loebl T, Raskin S, "A novel case report: acute manic psychotic episode after treatment with niacin", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Loebl T, Raskin S, "A novel case report: acute manic psychotic episode after treatment with niacin", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Niacin (7,974 reports)
- Clopidogrel (91,050 reports)
Browse all side effects of Niacin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on niacin and clopidogrel (the active ingredients of Niacin and Clopidogrel, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gastroesophageal Reflux Disease in Methylcobalamin, how severe and when it was recovered? - 4 seconds ago
- Benadryl and Idiopathic Pulmonary Fibrosis for Women aged 50-59 - 15 seconds ago
- Benadryl and Usual Interstitial Pneumonitis for Women aged 50-59 - 16 seconds ago
- Benadryl and Uip for Women aged 50-59 - 16 seconds ago
- Benadryl and Pulmonary Fibrosis for Women aged 50-59 - 16 seconds ago
- Benadryl and Ipf for Women aged 50-59 - 16 seconds ago
- Benadryl and Idiopathic Diffuse Interstitial Pulmonary Fibrosis for Women aged 50-59 - 17 seconds ago
- Benadryl and Cryptogenic Fibrosing Alveolitis for Women aged 50-59 - 17 seconds ago
- Benadryl and Cfa for Women aged 50-59 - 17 seconds ago
- Benadryl and Fibrosing Alveolitis for Women aged 50-59 - 18 seconds ago